Treatment for non-Hodgkin's lymphoma (stage I, II) of the elderly: Usefulness of local and regional irradiation and reduced dose chemotherapy

Gemcitabine: metabolism, mechanisms of action, and self-potentiation.

William Plunkett, Peng Huang, Yi-Zheng Xu et al. · PubMed · 1995 · 756 citations

MACOP-B Chemotherapy for the Treatment of Diffuse Large-Cell Lymphoma

Paul Klimo, Joseph M. Connors · Annals of Internal Medicine · 1985 · 669 citations

Lymphoid Neoplasia, Large-cell Lymphoma, Medicine +12

Effect of age on therapeutic outcome in advanced diffuse histiocytic lymphoma: the Southwest Oncology Group experience.

Dennis O. Dixon, Barbara A. Neilan, Siân Jones et al. · Journal of Clinical Oncology · 1986 · 362 citations

Cancer Management, Pathology, Pharmacotherapy +17

The importance of age in survival of patients treated with chemotherapy for aggressive non-Hodgkin's lymphoma.

Julie M. Vose, Jamés O. Armitage, Dennis D. Weisenburger et al. · Journal of Clinical Oncology · 1988 · 272 citations

Lymphoid Neoplasia, Geriatric Oncology, Oncology +13

Aggressive Chemotherapy for Diffuse Histiocytic Lymphoma in the Elderly: Increased Complications with Advancing Age

Jamés O. Armitage, Jane Potter · Journal of the American Geriatrics Society · 1984 · 230 citations